The global market for asthma drugs is set to hit $18 billion by 2021, according to new
research from pharmaceutical analyst firm, Datamonitor Healthcare. We take a closer
look at the current top 10 asthma drugs and predictions for this lucrative market.
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |